These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23725145)

  • 1. Soluble expression of recombinant human SMP30 for detecting serum SMP30 antibody levels in hepatocellular carcinoma patients.
    Zhang SC; Huang P; Zhao YX; Liu SY; He SJ; Xie XX; Luo GR; Zhou SF
    Asian Pac J Cancer Prev; 2013; 14(4):2383-6. PubMed ID: 23725145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of Serum SMP30 and Anti-SMP30 Antibody in Hepatocellular Carcinoma.
    Zheng SX; Xiang BD; Long JM; Qu C; Mo ZJ; Li K; Zhuang Y; Lv ZL; Zhou SF
    Lab Med; 2018 Jul; 49(3):203-210. PubMed ID: 29562243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma.
    Zhou SF; Mo FR; Bin YH; Hou GQ; Xie XX; Luo GR
    Clin Biochem; 2011 Mar; 44(4):331-6. PubMed ID: 21047503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma.
    Mo Z; Zheng S; Lv Z; Zhuang Y; Lan X; Wang F; Lu X; Zhao Y; Zhou S
    Sci Rep; 2016 Dec; 6():39376. PubMed ID: 27991558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
    Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
    J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay.
    Lv S; Wang JH; Liu F; Gao Y; Fei R; Du SC; Wei L
    BMC Gastroenterol; 2008 May; 8():17. PubMed ID: 18507831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between serum anti-P53 and familial clustering of hepatocellular carcinoma in Guangxi].
    Pang Y; Li GJ; Wu JZ; Wu JL; Chen WQ; Ning QY; Wei YH; Hu DF; Qin L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):206-9. PubMed ID: 22487835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for the production of soluble human senescence marker protein-30 in Escherichia coli.
    Choi MS; Saxena A; Chilukuri N
    Biochem Biophys Res Commun; 2010 Mar; 393(3):509-13. PubMed ID: 20152811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
    Wang J; Xu Y; Zhao H; Zhang X
    J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
    Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
    Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients.
    Dong XY; Peng JR; Ye YJ; Chen HS; Zhang LJ; Pang XW; Li Y; Zhang Y; Wang S; Fant ME; Yin YH; Chen WF
    Int J Cancer; 2008 May; 122(9):2038-43. PubMed ID: 18183594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.
    Zhao Q; Zhang GL; Zhu X; Su D; Huang ZL; Hu ZX; Peng L
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1520-1524. PubMed ID: 27987232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma.
    Ryder SD; Rizzi PM; Volkmann M; Metivier E; Pereira LM; Galle PR; Naoumov NV; Zentgraf H; Williams R
    J Clin Pathol; 1996 Apr; 49(4):295-9. PubMed ID: 8655704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progression to hepatocellular carcinoma.
    Masutomi K; Kaneko S; Yasukawa M; Arai K; Murakami S; Kobayashi K
    Oncogene; 2002 Aug; 21(38):5946-50. PubMed ID: 12185596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescence Marker Protein 30 (SMP30): A Novel Pan-Species Diagnostic Marker for the Histopathological Diagnosis of Breast Cancer in Humans and Animals.
    Baek SM; Lee SW; Kim TU; Choi SK; Yun S; Lee WJ; Han SH; Hong IH; Park SJ; Kim TH; Jeong KS; Park JK
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma.
    Ying X; Han SX; He CC; Zhou CY; Dong YP; Cai MJ; Sui X; Ma CX; Sun X; Zhang YY; Gou WL; Mason C; Zhu Q
    Oncotarget; 2017 Apr; 8(15):24828-24839. PubMed ID: 28186997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence marker protein-30 (SMP30) induces formation of microvilli and bile canaliculi in Hep G2 cells.
    Ishigami A; Fujita T; Inoue H; Handa S; Kubo S; Kondo Y; Maruyama N
    Cell Tissue Res; 2005 May; 320(2):243-9. PubMed ID: 15714273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
    Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
    Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.
    Jodo S; Kobayashi S; Nakajima Y; Matsunaga T; Nakayama N; Ogura N; Kayagaki N; Okumura K; Koike T
    Clin Exp Immunol; 1998 May; 112(2):166-71. PubMed ID: 9649177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senescence marker protein-30 regulates Akt activity and contributes to cell survival in Hep G2 cells.
    Matsuyama S; Kitamura T; Enomoto N; Fujita T; Ishigami A; Handa S; Maruyama N; Zheng D; Ikejima K; Takei Y; Sato N
    Biochem Biophys Res Commun; 2004 Aug; 321(2):386-90. PubMed ID: 15358188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.